Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice.
about
Immune response and immunopathology during toxoplasmosisEffects of Toxoplasma gondii infection on the brainInterferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brainLong-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic InfectionsNeurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection.The protein kinase double-stranded RNA-dependent (PKR) enhances protection against disease cause by a non-viral pathogen.In vitro infection of human nervous cells by two strains of Toxoplasma gondii: a kinetic analysis of immune mediators and parasite multiplication.Partially protective vaccination permits the development of latency in a normally virulent strain of Toxoplasma gondii.VCAM-1/α4β1 integrin interaction is crucial for prompt recruitment of immune T cells into the brain during the early stage of reactivation of chronic infection with Toxoplasma gondii to prevent toxoplasmic encephalitis.Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.In the absence of endogenous gamma interferon, mice acutely infected with Neospora caninum succumb to a lethal immune response characterized by inactivation of peritoneal macrophages.Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the braingp130 at the nexus of inflammation, autoimmunity, and cancer.Interferon-γ restricts Toxoplasma gondii development in murine skeletal muscle cells via nitric oxide production and immunity-related GTPases.CXCL9 is important for recruiting immune T cells into the brain and inducing an accumulation of the T cells to the areas of tachyzoite proliferation to prevent reactivation of chronic cerebral infection with Toxoplasma gondii.IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondiiInterleukin-6-driven inflammatory response induces retinal pathology in a model of ocular toxoplasmosis reactivation.Interleukin-6 and chronic inflammationFeeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice.Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection.Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects.Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease.Neonatal levels of acute phase proteins and later risk of non-affective psychosis.IL-6 promotes NK cell production of IL-17 during toxoplasmosis.A toxoplasma patatin-like protein changes localization and alters the cytokine response during toxoplasmic encephalitis.Toxoplasma gondii and the blood-brain barrier.Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases.Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii.CD2 deficiency partially prevents small bowel inflammation and improves parasite control in murine Toxoplasma gondii infection.Intracellular transport of Toxoplasma gondii through the blood-brain barrierMigratory activation of primary cortical microglia upon infection with Toxoplasma gondii.
P2860
Q24612341-3C7F2BFB-1BBF-4A04-B4D9-86FA225C5AB1Q24656964-8325009F-CB63-4F5E-AB68-3F6B5889AFA1Q27011746-598BC78C-7D4B-4944-B466-92A91C738809Q28082315-F6B5BF16-F5B5-4570-9D3B-70F7982B82B2Q30484779-0638C7AF-73B7-4F02-BAAB-7C9357EBE59BQ31129671-91711611-2539-4CE0-836A-4C33816C4132Q33700082-AB4EE4FA-9204-4C33-B001-DDA5505923FEQ33762617-86A7F100-ECA2-423C-A0E5-68082E919661Q33899681-DF617A5D-3AF2-45B7-924B-2D8F67A10993Q33975360-3163C11B-54C8-497E-B455-2F8561557F0CQ33999302-EE975D4D-039D-47E4-9E23-C90F4EAF87E7Q34007181-A7F2859A-4749-4034-BE40-BCFBE8C7964AQ34378756-499C488B-5EDB-4B3C-B7D9-2FC959095DA6Q34425347-491D70C1-B3E8-45ED-80C2-6F4102276E57Q35008494-937837EA-F057-463D-9576-C63A6795C4DCQ35058854-9724AE75-C25E-47ED-A0D1-34F36EBDCC8CQ35439628-CBE1B572-3BFE-4749-9B45-A37B74F177A8Q35578869-C0F1108B-916A-46CC-A27E-85DC6468FE43Q35989119-D0BF634E-F3C2-4FC7-B852-CC634A3241C4Q36055984-69A375F3-32D2-469D-9D92-CED373301600Q36401305-5EFE4568-D9D8-4071-8D79-B8D6DA64D70DQ36445241-570EDFC0-1C57-4C84-BBB1-C9246839649BQ36664739-6EE8A8A6-CAFE-45BA-B8EE-9410FA2DCF20Q37132980-B2C70AF7-64BE-42A7-BFB7-5CD7AE21D455Q37546358-85F54E79-72DF-40B4-A337-B105572F4C13Q37998386-0CED7B9D-34A8-46FB-84C3-1927D27965CDQ38966132-97A5DA05-6417-406D-A9FD-435AC8A7C0BEQ39523162-4886F36E-A216-4A8C-8246-BA40C21C3D77Q42055566-92A8974F-8EB2-4D1A-924E-AB5672F4236DQ42758621-ADF5128D-AB45-4478-8EF5-11952D351283Q42849627-541FC24D-D093-4F8C-AA8A-D49D1A9E9642
P2860
Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Impaired resistance to the dev ...... interleukin-6-deficient mice.
@ast
Impaired resistance to the dev ...... interleukin-6-deficient mice.
@en
type
label
Impaired resistance to the dev ...... interleukin-6-deficient mice.
@ast
Impaired resistance to the dev ...... interleukin-6-deficient mice.
@en
prefLabel
Impaired resistance to the dev ...... interleukin-6-deficient mice.
@ast
Impaired resistance to the dev ...... interleukin-6-deficient mice.
@en
P2093
P2860
P1476
Impaired resistance to the dev ...... interleukin-6-deficient mice.
@en
P2093
J S Remington
O Liesenfeld
S A Dalrymple
T A Nguyen
P2860
P304
P407
P577
1997-06-01T00:00:00Z